More on Anti-Insulin Receptor Antibody in Malignant Insulinoma and Refractory Hypoglycemia. Reply

N Engl J Med. 2023 Oct 26;389(17):1635. doi: 10.1056/NEJMc2311041.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Hypoglycemia* / etiology
  • Insulinoma* / complications
  • Pancreatic Neoplasms* / complications